Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (44)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Gebhardt, R.
Right arrow Articles by Williams, G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gebhardt, R.
Right arrow Articles by Williams, G. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1989 Oxford University Press

research-article

Glutamine synthetase heterogeneous expression as a marker for the cellular lineage of preneoplastic and neoplastic liver populations

Rolf Gebhardt, Takuji Tanaka 1 2 and Gary M. Williams 1

Physiologisch-chemisches Institut der Universitat Hoppe-Seyler-Strasse 4, D-7400 Tubingen, FRG
1American Health Foundation 1, Dana Road, Valhalla, NY 10595, USA
2Presenr address: Department of Pathology, Gifu University, School of Medicine Gifu City 500, Japan

The distribution of glutamine synthetase (GS) in rat liver and in putative preneoplastic and neoplastic lesions was studied at stages of hepatocarcinogenesis induced by diethylnltros amine (DEN), 2-acetylaminofluorene (AAF) and aflatoxin B1 (AFB1) using immunohistochemistry. in control rats, GS was localized entirely to rings 1–3 cells deep surrounding the central veins. Exposure to DEN or AAF resulted in a reduction of these GS-positive (GS+) zones by 96 and 61% respectively, due to necrosis of the cells in this compartment, while AFB1 had little effect (<14%). At later times GS+ foci, adenomas and carcinomas developed in animals exposed to DEN or AAF, but not AFB1 corresponding to the acute effects. Small GS+ foci also identified by other phenotypic abnormalities (e.g. {gamma}-glutamyltransferase) were exclusively associated with the regenerating GS+ zone as were a few collections of GS+ hepatocytes, the nature of which was uncertain. Although accounting for a very small fraction (<3%) of total foci, these GS+ foci or GS+ hepatocytes apparently gave rise to a substantial fraction of adenomas that were GS+ (DEN: 43% and AAF: 33%) and an even higher percentage of GS+ carcinomas (DEN: 59% and AAF: 39%). No GS+ neoplasms were induced by AFB1 Statistical evaluation of these data strongly suggests that GS+ neoplasms originate through initiation of hepatocytes which possess this particular phenotype. Thus, GS might serve as a specific marker for tracing cell lineage relationships dur ing hepatocarcinogenesis. The GS+ phenotype which confers glutamine independence may also provide a growth ad vantage.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Toxicol PatholHome page
G. M. Williams, M. J. Iatropoulos, and A. M. Jeffrey
Thresholds for the Effects of 2-Acetylaminofluorene in Rat Liver
Toxicol Pathol, February 1, 2004; 32(2_suppl): 85 - 91.
[Abstract] [PDF]


Home page
Mol. Endocrinol.Home page
F. Gaunitz, K. Heise, and R. Gebhardt
A Silencer Element in the First Intron of the Glutamine Synthetase Gene Represses Induction by Glucocorticoids
Mol. Endocrinol., January 1, 2004; 18(1): 63 - 69.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
O. Moennikes, S. Stahl, P. Bannasch, A. Buchmann, and M. Schwarz
WY-14,643-mediated promotion of hepatocarcinogenesis in connexin32-wild-type and connexin32-null mice
Carcinogenesis, September 1, 2003; 24(9): 1561 - 1565.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
M. Schwarz, I. Wanke, U. Wulbrand, O. Moennikes, and A. Buchmann
Role of Connexin32 and {beta}-Catenin in Tumor Promotion in Mouse Liver
Toxicol Pathol, January 1, 2003; 31(1): 99 - 102.
[Abstract] [PDF]


Home page
Cancer Res.Home page
S. Loeppen, D. Schneider, F. Gaunitz, R. Gebhardt, R. Kurek, A. Buchmann, and M. Schwarz
Overexpression of Glutamine Synthetase Is Associated with {beta}-Catenin-Mutations in Mouse Liver Tumors during Promotion of Hepatocarcinogenesis by Phenobarbital
Cancer Res., October 15, 2002; 62(20): 5685 - 5688.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
K. Nicholes, S. Guillet, E. Tomlinson, K. Hillan, B. Wright, G. D. Frantz, T. A. Pham, L. Dillard-Telm, S. P. Tsai, J.-P. Stephan, et al.
A Mouse Model of Hepatocellular Carcinoma : Ectopic Expression of Fibroblast Growth Factor 19 in Skeletal Muscle of Transgenic Mice
Am. J. Pathol., June 1, 2002; 160(6): 2295 - 2307.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
W. H. Lamers, J. L.M. Vermeulen, T. B.M. Hakvoort, and A. F.M. Moorman
Expression Pattern of Glutamine Synthetase Marks Transition from Collecting into Conducting Hepatic Veins
J. Histochem. Cytochem., December 1, 1999; 47(12): 1507 - 1512.
[Abstract] [Full Text]


Home page
Toxicol PatholHome page
F. Stenback, R. Gebhardt, H. Sirma, J.-M. Garbay, and G. M. Williams
Sequential Functional and Morphological Alterations During Hepatocarcinogenesis Induced in Rats by Feeding of a Low Dose of 2-Acetylaminofluorene
Toxicol Pathol, November 1, 1994; 22(6): 620 - 632.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.